Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1596, 2007-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The risk of chloroquine- or hydroxychloroquine-induced vision disorders appears to be low
Inpharma, Vol. 1, Iss. 1305, 2001-01 ,pp. :
DM risk lower with verapamil SR than with atenolol
Reactions Weekly, Vol. 1, Iss. 1129, 2006-01 ,pp. :
Lower stroke and MI risk with pioglitazone in T2DM
Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. :
DM industry expresses interest in high-risk infant management
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 396, 2003-01 ,pp. :
Diabetes DM programme worthwhile to reduce CV risk factors
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 477, 2005-01 ,pp. :